Diagnostic and Therapeutic Approaches for First Visits of Patients with Crohn’s Disease
DOI:
https://doi.org/10.22516/25007440.438Keywords:
Crohn’s disease, inflammatory bowel disease, checklist, vaccination, tuberculosisAbstract
Crohn’s disease (CD) is the fundamental protagonist of so-called Inflammatory Bowel Disease (IBD). This is a term by which several entities are known. Its origin is multifactorial. It is characterized by chronic and recurrent inflammation with different degrees of involvement of the gastrointestinal tract, but also with potential commitment of other organs.
In the last decade there has been a renewed interest in these entities due to a boom in innovative medicines. Despite these medications, CD and IBD remain incurable. The increasing incidence of CD in our country requires us both scientifically and morally to develop basic, practical guidelines with checklists adapted to our environment for the diagnosis and management of CD through the first consultations of patients
Downloads
References
Sands, B. Histopathology in inflammatory bowel disease. Gastroenterology 2000; 118: S68-S82.
Sicilia B, Vicente R, Gomollon F. Enfermedad de Crohn y colitis ulcerosa: discusión de la epidemiologia clínica. Acta Gastroenterol Latinoam 2009; 39: 135-145.
Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-1794.
Shanahan F, Bernstein CN. The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 2009; 25: 1-5.
Moum B, Ekbom A. Epidemiology of inflammatory bowel disease – methodological considerations. Digest Liver Dis 2002; 34: 364-369.
Loftus CG, Loftus EV Jr., Harmsen WS, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13: 254-61.
Wilson B, et al. Presentado en el 7th Congress of ECCO, Feb 16-18, 2012 Barcelona, Spain. Poster 406.
Arguello M, Archila PE, Sierra F, et al. Enfermedad inflamatoria intestinal. Rev Col Gastroenterol 1991; 6(4): 237-272.
Juliao F, Ruiz MH, Florez JF, et al. Fenotipo e historia natural de la enfermedad inflamatoria intestinal en un centro de referencia en Medellín-Colombia. Rev Col Gastroenterol 2010; 25(3): 240-251.
Di Palma JA, Farraye FA. Crohn’s disease: the first visit. Gastroenterology and Hepatology 2011; 7(3): 163-169.
Vatn M H. Natural history and complications of IBD. Curr Gastroenterol Rep 2009; 11(6): 481-7.
Lichtenstein GR, Hanauer SB, Sandborn WJ, et al. Practice parameters committee of the American college of gastroenterology . Management of crohn´s disease in adults. Am J Gastroenterol 2009; 104: 465-483.
Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19(Suppl. A): 5-36.
Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Lofberg R, Modigliani R, Present DH, Rutgeerts P, Scholmerich J, Stange EF, Sutherland LR. Review of Activity Indices and Efficacy Endpoints for Clinical Trials of Medical Therapy in Adults with Crohn´s Disease. Gastroenterology 2002; 122: 512-530.
Vermeire S. Serologic markers in the diagnosis and management of IBD. Gastroenterol Hepatol. 2007; 3:424-426.
Schoepner AM, Beglinger C, Starumann A, et al. Fecal calprotectine correlates more closely with the Simple Endoscopic Score for Crohn´s disease (SES-CD) than CRP, blood leukocytes and the CDAI. Am J Gastroenterol 2010; 105: 162-169.
Advisory Committe on Inmunization Practices. Recommended adult inmunization Schedule 2010. Ann Intern Med 2010; 152: 36-39.
Bourreille A, et al. Role of small -bowel endoscopy in IBD: international OMED -ECCO consensus. Endoscopy 2009; 41: 618 -637.
Nikolaus S, Schreiber S. Diagnostics of inflammatory Bowel Disease. Gastroenterology 2007; 133: 1670.
Jenkins D, Balsitis M, Gallivan S, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology initiative. J Clin Pathol 1997; 50: 93-105.
Horsthuis K, Bipat S, Bennink R, Stoker J. Inflammatory Bowel Disease with US, MR, SCintigraphy, and CT: Metaanalysis of Prospectives Studies. Radiology 2008; 24 (1): 64-79
Fiorino G, Bonifacio C, Peyrin-Biroulet L, Minuti F, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inflamm Bowel Dis 2011; 17(5): 1073-80.
Jowet SL, Seal CJ, Barton JR, et al. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol 2001; 96: 2921-2928.
Wasan SK, Baker SE, Skolnik PR, et al. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol 2010; 105: 1231-1238.
Advisory Commmitte on Inmunization Practices, Recommended adult immunization schedule: United States 2010. Ann Inter Med 2010; 152: 36-39.
Laass MW, Roggenbuck D, Conrad K. Diagnosis and classification of Crohn’s disease, Autoimmun Rev (2014), online.
Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem 2006; 52: 171-81.
Smith LA, Gaya DR. Utility of fecal calprotectine analysis in adult inflammatory bowel disease. World J Gastroenterol 2012; 18 (46): 6782-6789.
Cabriadaa J, Vera I, Domènechc E, et al. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el uso de fármacos antifactor de necrosis tumoral en la enfermedad inflamatoria intestinal (2013). Gastroenterol Hepatol 2013; 36(3): 127-146.
Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn’s Relapse Prevention Trial. Am J Gastroenterol 1996; 91(8): 1571-8.
Rahier JF, Ben-Horin S, Chowers Y, et al. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. Journal of Crohn and Colitis 2009.
Harvey RF, Bradshaw JM. A simple index of Crohn disease activity. Lancet 1980; 315(8167): 514.
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
